SMTL ID : 7e0a.1

X-ray structure of human PPARgamma ligand binding domain-saroglitazar co-crystals obtained by co-crystallization

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.77 Å

Oligo State

monomer

Ligands

1 x EWR: (2S)-2-ethoxy-3-[4-[2-[2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl]ethoxy]phenyl]propanoic acid(Non-covalent)

EWR.1: 27 residues within 4Å: Chain A: L.58, E.62, F.67, H.69, I.84, F.85, G.87, C.88, Q.89, R.91, S.92, H.126, I.129, Y.130, L.133, L.136, L.143, I.144, S.145, E.146, M.151, F.166, M.167, H.252, L.256, L.272, Y.276 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.67, A:F.85, A:R.91, A:I.129, A:L.133, A:L.136, A:I.144, A:I.144, A:F.166 Hydrogen bonds: A:S.92, A:Y.276 Salt bridges: A:H.126, A:H.252

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Honda, A. et al., Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR alpha / gamma Dual Agonist. Biol.Pharm.Bull. (2021)

Release Date

2021-09-08

Peptides

Isoform 2 of Peroxisome proliferator-activated receptor gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Isoform 2 of Peroxisome proliferator-activated receptor gamma